News Bevacizumab Shows No Benefit in Advanced-Stage AMD by Medscape • 2012/07/16 • 0 Comments Intravitreal bevacizumab does not benefit patients with advanced neovascular age-related macular degeneration (AMD) and very poor vision, according to a small study. Reuters Health Information Full Story →